About FibroGen, Inc.
https://www.fibrogen.comFibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs.
CEO
Thane Wettig
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Medical - Pharmaceuticals
Sector Healthcare
Went public January 8, 2026
Method of going public IPO
Full time employees 225
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0
Market Cap $38.43 M
52w High $21.95
52w Low $4.85
P/E -0.73
Volume 26.43K
Outstanding Shares 4.05M
About FibroGen, Inc.
https://www.fibrogen.comFibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs.
CEO
Thane Wettig
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Medical - Pharmaceuticals
Sector Healthcare
Went public January 8, 2026
Method of going public IPO
Full time employees 225
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0